Last: | $74.65 |
---|---|
Change Percent: | -0.52% |
Open: | $74.94 |
Close: | $74.65 |
High: | $74.94 |
Low: | $74.06 |
Volume: | 6,977,378 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$74.65 | $74.94 | $74.65 | $74.94 | $74.06 | 6,977,378 | 05-17-2024 |
$74.55 | $74.43 | $74.55 | $74.765 | $74.175 | 5,636,940 | 05-16-2024 |
$74.45 | $73.86 | $74.45 | $74.6713 | $73.86 | 4,474,665 | 05-15-2024 |
$73.49 | $72.6 | $73.49 | $73.64 | $72.31 | 5,848,511 | 05-14-2024 |
$72.81 | $73.68 | $72.81 | $73.83 | $72.66 | 6,182,025 | 05-13-2024 |
$73.69 | $74.2 | $73.69 | $74.3 | $73.535 | 3,790,579 | 05-10-2024 |
$74.1 | $72.74 | $74.1 | $74.145 | $72.74 | 6,134,777 | 05-09-2024 |
$72.72 | $73.51 | $72.72 | $73.66 | $72.61 | 5,036,563 | 05-08-2024 |
$73.43 | $72.7 | $73.43 | $73.5 | $72.62 | 4,151,544 | 05-07-2024 |
$72.55 | $73.04 | $72.55 | $73.27 | $72.42 | 4,922,960 | 05-06-2024 |
$72.85 | $72.22 | $72.85 | $73.075 | $71.82 | 7,452,084 | 05-03-2024 |
$72.03 | $72.47 | $72.03 | $72.56 | $70.97 | 7,610,487 | 05-02-2024 |
$72.21 | $71.61 | $72.21 | $72.99 | $71.144 | 6,021,096 | 05-01-2024 |
$71.87 | $72.34 | $71.87 | $72.79 | $71.735 | 7,729,794 | 04-30-2024 |
$72.5 | $73.08 | $72.5 | $73.125 | $71.75 | 9,460,687 | 04-29-2024 |
$73.17 | $72.88 | $73.17 | $73.613 | $72.64 | 8,786,294 | 04-26-2024 |
$73.26 | $73.13 | $73.26 | $73.635 | $72.91 | 8,171,122 | 04-25-2024 |
$72.91 | $73.14 | $72.91 | $74.39 | $72.55 | 14,206,417 | 04-24-2024 |
$68.99 | $68.32 | $68.99 | $69 | $67.8 | 9,075,682 | 04-23-2024 |
$68.02 | $67.63 | $68.02 | $68.605 | $66.8 | 7,659,790 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints PR Newswire Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker ...
HealthEquity (NASDAQ: HQY) recently announced the completion of the acquisition of Conduent's BenefitWallet Health Savings Account portfolio. I...
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommends buying sports betting company DraftKings Inc. (NASDAQ:DKNG), proclaim...